Our Take
Resilient's claim to detect burnout early relies on a licensed proprietary tool and data fusion, but the interview offers no independent validation or customer results to support the detection accuracy.
Why it matters
Corporate wellness is a $65B market projected to double by 2034, and burnout carries documented trillion-dollar costs in the US. Early detection plays directly into employer ROI, so any vendor claiming to predict stress before crisis matters to the buying conversation.
Do this week
Enterprise benefits leads: request Resilient's peer-reviewed validation data or independent case study results before piloting; vendor claims about early detection require third-party proof.
Resilient CEO on market strategy and product differentiation
Max Grossenbacher, CEO of Resilient, outlined the company's market positioning and product approach in an interview with CB Insights. The global corporate wellness market is worth $65B and is projected to reach $130B by 2034 (company-reported). In Switzerland, burnout alone costs employers up to 10B Swiss francs annually. The US figure is estimated at $300B per year, with chronic stress itself carrying a broader $1T annual cost (per Pete Schnell, cited by Grossenbacher).
Resilient entered the market through Switzerland, which Grossenbacher described as one of the hardest enterprise markets to crack, before expanding to the US. The company differentiates through a proprietary licensed tool called STOA, combined with wearables and AI coaching. Grossenbacher characterized competitors like WellHub and nilo.health as either generic or reactive, whereas Resilient focuses on detecting burnout before it escalates into crisis.
The company worked closely with Swiss psychiatrists, psychologists, and psychotherapists to inform its support delivery. Resilient employs data fusion algorithms designed to detect patterns across multi-model data streams and predict or prevent burnout and stress chronification, according to Grossenbacher.
The burnout cost thesis drives buyer urgency
The headline numbers are the real argument: $300B in annual US burnout costs and $1T in chronic-stress costs create measurable pressure on employer health spend. If Resilient can demonstrate ROI by preventing even a fraction of that loss, the pitch is straightforward. Early detection is not a wellness nicety but a cost-control mechanism.
The Switzerland beachhead is also instructive. Enterprise software vendors often use smaller, highly regulated markets to refine product and sales motion before entering the US. Switzerland's labor protections and employer liability exposure around burnout may have forced precision in the product earlier than a US-first approach would have.
What remains unverified is the detection accuracy claim. Grossenbacher did not cite published benchmarks, independent validation, or customer outcomes showing that the STOA tool or data fusion algorithms actually catch burnout earlier or with higher sensitivity than existing alternatives.
Evaluate detection claims with proof in hand
Wellness buyers tend to move slowly and rely on peer references. Ask Resilient for independent clinical validation, published results on sensitivity and specificity of early detection, and customer case studies showing measurable prevention outcomes (reduced sick days, retained employees, cost per case averted). A proprietary tool is a moat only if it works; without third-party evidence, it is a specification. Compare STOA's detection accuracy directly against simpler baselines (e.g., standard burnout surveys plus wearable vital signs) to confirm that the added complexity delivers a real signal lift.